Learn more

PROGRAPHARM LAB

Overview
  • Total Patents
    54
About

PROGRAPHARM LAB has a total of 54 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), France and Australia. Its main competitors in its focus markets pharmaceuticals and machines are SINT SA, SUNSHINE ABRAHAM and BIOMIRA USA INC.

Patent filings per year

Chart showing PROGRAPHARM LABs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Gendrot Edouard 33
#2 Chauveau Charles 22
#3 Cousin Gerard 22
#4 Bruna Etienne 15
#5 Demichelis Alain Gilles 14
#6 Ragot Francoise 14
#7 Nouri Noureddine 12
#8 Clee-Bouvet Marie-Christine 10
#9 Clee Marie-Christine 6
#10 Louvel Pascal Claude Michel 5

Latest patents

Publication Filing date Title
US6039979A Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
HK1012553A1 Method for making chewable tablets based on troxerutine calcium carbonate calcium phosphate arginine aspartate arginine glutamate amoxicillin a combination of calcium carbonate and magnesium carbonate and a combination of aluminium hydroxide and magnesium hydroxide
FR2769854A1 New process for obtaining microspheres and the products thus produced
FR2781793A1 Process for producing coated gabapentine granules
FR2778848A1 Multiparticulate pharmaceutical formula with pulsed release and its preparation method
FR2769853A1 New process for obtaining microspheres and the products thus produced
FR2766089A1 Improved multiparticular tablet with rapid delivery
FR2761605A1 Multiparticular pharmaceutical form, its constituent particles, method and plant for their manufacture
FR2754710A1 Process for the preparation of a multiparticular pharmaceutical form with controlled release plurisequentielle
FR2732896A1 Transdermal pharmaceutical form for percutaneous administration of apomorphine
US5464632A Rapidly disintegratable multiparticular tablet
CA2092074A1 Rapidly disintegratable multiparticulate tablet
US5229135A Sustained release diltiazem formulation